InvestorsHub Logo
Followers 2
Posts 319
Boards Moderated 0
Alias Born 08/29/2018

Re: ranchhand71 post# 26307

Thursday, 05/13/2021 2:02:56 PM

Thursday, May 13, 2021 2:02:56 PM

Post# of 27409
Nice find Raunch! I see we are down just a hair today, could be a good entry point. In speaking to some well respected and very knowledgable investors here in Cali they seem a little confused by the decision of our trusted advisor Dr. J Kellum of Pittsburgh to sign with EDTXF. I don't see it as an issue however they do and suggest it has been putting pressure on the share price as of late. Hemodefend is surely a wildcard that could propel us to new heights as it is unique and super cool! My only concern with future earnings is the lack of expense we have had on the clinical front. For the last couple years our expense in terms of clinical programs has been quite low. When we start ramping up the FDA process in all areas...Sepsis, cardiac surgery and of course Hemodefend, our expenses will no doubt elevate and will impact the bottom line. Hopefully the rising revenues will offset this required expense. I see this as a long term positive however it would be foolish not to recognize the clinical expense holiday we have been enjoying over the last couple years. Just one Golden State resident's opinion. Best of luck to all holders and long the beads!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CTSO News